Clinical Trial Update: MAGIC Cell-5-Combicytokine Trial [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for MAGIC Cell-5-Combicytokine in acute myocardial infarction covering Phase 2 and Phase 3; the current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• MAGIC Cell-5-Combicytokine

Snippet

Sponsor: Seoul National University Hospital | Conditions: Acute Myocardial Infarction | Phase 2, Phase 3 | Status: UNKNOWN